Learn More
Medchemexpress LLC 2-(4-oxo-1,2,3-benzotriazin-3-yl)-N-[(1S)-1-[4-(trifluoromethoxy)phenyl]ethyl]acetamide | 1929519-13-0 | MFCD32858822 | 99.9% | 392.33 g·mol^-1 | C18H15F3N4O3 | 5 MG

Supplier: Medchemexpress LLC HY1322285MG
Zelatriazin is a selective GPR139 agonist provided for research use to study GPR139-mediated signaling and potential treatments for negative symptoms of schizophrenia. Supplied as a high-purity solid, it includes validated activity and stability information suitable for in vitro and in vivo laboratory workflows.
- Selective GPR139 agonist with EC50 ≈ 22 nM.
- High purity (≈99.9%) suitable for research assays.
- Molecular formula C18H15F3N4O3; molecular weight 392.33 g·mol^-1.
- Available in small research sizes (for example, 5 mg).
- Powder stability: -20°C up to 3 years; 4°C up to 2 years.
- Solvent solution stability: -80°C up to 6 months; -20°C up to 1 month.
- For research use only; not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.